Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation save search
Genetic Technologies Limited Announces Updated Investor Presentation
Published: 2023-08-09 (Crawled : 12:00) - globenewswire.com
GENE | News 0 d | $2.36 -25.32% -33.9% 88K
|
Health Technology
|
| O: 2443.05%
H: 4.17%
C: -4.95%
genetic presentation technology
Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer
Published: 2021-11-09 (Crawled : 12:26) - renovorx.com
RNXT | $1.19 5.07% 5.3K
|
|
| O: 67.28%
H: 38.23%
C: -9.83%
presentation treatment potential therapy cancer pancreatic pancreas
Kiora Pharmaceuticals Receives Investigational New Drug Approval for Phase 2 Study of KIO-101 for Treatment of Ocular Presentation of Autoimmune Diseases
Published: 2023-02-07 (Crawled : 15:00) - biospace.com/
KPRX | $0.4913 -2.94% -3.03% 160K
|
Manufacturing
|
| O: 64.63%
H: 9.07%
C: -15.74%
kio-101 treatment pharmaceuticals drug ocular approval presentation study
Lipella Pharmaceuticals Successfully Completes Phase 2a Clinical Trial; Announces Late-Breaking Presentation at the Annual Meeting of the American Urological Association
Published: 2023-03-16 (Crawled : 13:00) - biospace.com/
LIPO | $0.706 -5.74% -6.09% 19K
|
|
| O: 51.37%
H: 5.77%
C: -10.11%
association presentation pharmaceuticals meeting
Finch Therapeutics to Present at Upcoming Virtual Investor Conferences
Published: 2021-05-28 (Crawled : 13:00) - globenewswire.com
FNCH | $2.4 -4.76% -5.0% 26K
|
Professional, Scientific, and T...
|
| O: 43.51%
H: 0.0%
C: -33.98%
conference presentation therapeutics
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
LGVN | News P 0 d | $2.005 -4.07% -4.24% 990K
|
|
| O: 41.42%
H: 42.68%
C: 22.59%
conference disease association alzheimer’s presentation international research for trial
Affimed Announces Presentation at AACR Highlighting Initial Data from Phase 1 Study of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13
Published: 2021-04-09 (Crawled : 11:00) - affimed.com
AFMD | $5.1 -2.49% -2.55% 90K
|
Health Technology
|
| O: 30.16%
H: 4.19%
C: -5.16%
presentation blood phase 1 phase 3 phase 2
Vivos Therapeutics’ SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep ApneaStudy Recently Presented at the SLEEP 2022 Annual Meeting
Published: 2022-06-14 (Crawled : 13:20) - biospace.com/
VVOS | $2.66 -2.66% 63K
|
Health Technology
|
| O: 27.78%
H: 0.0%
C: -30.43%
presentation
Elliott Sends Letter and Presentation to the Board of Goodyear
Published: 2023-05-11 (Crawled : 13:00) - prnewswire.com
GT | $11.72 -2.09% -2.13% 3.6M
|
Consumer Durables
|
| O: 22.78%
H: 5.21%
C: -1.11%
presentation
Borr Drilling Limited – Q3 2021 Presentation
Published: 2021-11-05 (Crawled : 13:00) - borrdrilling.com
BORR | $5.51 -3.84% 0.91% 3.4M
|
Industrial Services
|
| O: 22.02%
H: 0.75%
C: -6.77%
presentation
Presentation of Preclinical Study Highlighting Anti-Cancer Activity of Rencofilstat in Combination with Proteosome Inhibitors
Published: 2023-01-10 (Crawled : 22:00) - contravir.com
HEPA | $2.1 -1.41% -1.43% 28K
|
Health Technology
|
| O: 21.58%
H: 19.59%
C: 11.39%
preclinical presentation study
Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA
Published: 2021-10-07 (Crawled : 13:15) - biospace.com/
AVGR | $3.89 6.0% 5.66% 17K
|
Health Technology
|
| O: 20.26%
H: 1.81%
C: -6.35%
trial presentation
Veru Announces the Presentation of Positive Phase 2 Clinical Data of Enobosarm in AR+ER+HER2- Metastatic Breast Cancer Patients that Have Progressed on Estrogen Blocking Agents and CDK 4/6 Inhibitor at the ESMO Breast Cancer Congress 2021
Published: 2021-05-05 (Crawled : 13:00) - globenewswire.com
VERU | $1.42 22.41% 18.31% 7M
|
Health Technology
|
| O: 20.23%
H: 6.88%
C: -15.97%
presentation phase 2 positive cancer breast cancer her2+ her2- her2 metastatic breast cancer
Navidea Biopharmaceuticals Announces Presentation of Results from its Two Phase 2B Clinical Trials in Rheumatoid Arthritis at Upcoming American College of Rheumatology Annual Meeting
Published: 2022-09-15 (Crawled : 13:00) - biospace.com/
NAVB | $0.042 50.69% 12K
|
Health Technology
|
| O: 19.95%
H: 0.0%
C: -6.67%
trials meeting presentation results phase 2b
PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study in Oral Presentation at ASCO 2021 Annual Meeting
Published: 2021-06-08 (Crawled : 11:00) - biospace.com/
PDSB | $2.89 6.25% 5.88% 1.1M
|
Health Technology
|
| O: 18.72%
H: 3.94%
C: 0.0%
presentation phase 2 biotech iot
CORRECTING AND REPLACING -- PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study in Oral Presentation at ASCO 2021 Annual Meeting
Published: 2021-06-08 (Crawled : 12:00) - globenewswire.com
PDSB | $2.89 6.25% 5.88% 1.1M
|
Health Technology
|
| O: 18.72%
H: 3.94%
C: 0.0%
presentation phase 2 biotech iot
Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience
Published: 2023-07-13 (Crawled : 14:00) - biospace.com/
SNPX | $4.66 -2.92% -3.0% 42K
|
Professional, Scientific, and T...
|
| O: 16.14%
H: 88.0%
C: 4.0%
disease world presentation international research alzheimer's benefits
BioPlus Acquisition Files Investor Presentation on $195M Avertix Medical Deal
Published: 2023-06-14 (Crawled : 17:00) - spacfeed.com
FATP | $10.915 -0.14% 8.2K
|
n/a
|
| O: -0.56%
H: 0.28%
C: 0.09%
NKLA | $0.6601 2.6% 2.53% 45M
|
Consumer Durables
|
| O: 14.88%
H: 11.9%
C: 2.86%
presentation acquisition medical deal
Vaxart to Present at the World Vaccine Congress Washington 2021
Published: 2021-04-29 (Crawled : 12:15) - globenewswire.com
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: 14.81%
H: 13.52%
C: -4.95%
vaccine presentation
VistaGen Therapeutics to Present at Two Investor Conferences in June
Published: 2021-05-20 (Crawled : 12:00) - ir.vistagen.com
VTGN | $4.69 0.43% 0.43% 200K
|
Health Technology
|
| O: 14.35%
H: 2.28%
C: -1.9%
conference presentation therapeutics
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.